Inhalation Gases or Gaseous Mediators As Neuroprotectants for Cerebral Ischaemia

E-ISSN： 1873-5592|14|1|56-73

ISSN： 1389-4501

Source： Current Drug Targets, Vol.14, Iss.1, 2013-01, pp. : 56-73

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dichloroacetate and cerebral ischaemia therapeutics

By Marangos P.J. Turkel C.C. Dziewanowska Z.E. Fox A.W.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 4, 1999-04 ,pp. : 373-382

Informa Healthcare

Access to resources Recommend Favorite

Inflammatory Mediators in Smoke Inhalation Injury

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 1, 2009-03 ,pp. : 63-69

Bentham Science Publishers

Access to resources Recommend Favorite

Calcium channel blockers in cerebral ischaemia

By Barone F.C. Feuerstein G.Z. A Spera R.P.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 5, 1997-05 ,pp. : 501-519

Informa Healthcare

Access to resources Recommend Favorite

Desmoteplase as a potential treatment for cerebral ischaemia

By Patel Rikesh Ispoglou Sevasti Apostolakis Stavros

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 6, 2014-06 ,pp. : 865-873

Informa Healthcare

Access to resources Recommend Favorite

Glutamate antagonists in animal models of cerebral ischaemia

By McCulloch J.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 170-170

Elsevier

Access to resources Recommend Favorite